Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mansonella Perstans on Praziquantel Response in Schistosomiasis
NCT02734186Phase 4Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of praziquantel in schistosomiasis, sponsored by National Institute of Allergy and Infectious Diseases. Planned start Apr 2016; status: withdrawn.
02
Drugs
praziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT02734186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734186.